3,5-disubstituted pyrid-2-ones useful as inhibitors of Tec family of non-.receptor tyrosine kinases

Details for Australian Patent Application No. 2006285145 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors Charrier, Jean-Damien; Ramaya, Sharn; Mortimore, Michael; Golec, Julian M.C.; Durrant, Steven; Jimenez, Juan-Miguel

Agent Cullen & Co

Pub. Number AU-A-2006285145

PCT Pub. Number WO2007/027528

Priority 60/712,457 29.08.05 US

Filing date 25 August 2006

Wipo publication date 8 March 2007

International Classifications

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/444 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

C07D 213/64 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

17 April 2008 PCT application entered the National Phase

  PCT publication WO2007/027528 Priority application(s): WO2007/027528

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006285146-Processes for preparing MTT zeolites using nitrogen-containing organic compounds

2006285144-Isoindole-imide compounds and compositions comprising and methods of using the same